Patients with metastatic pancreatic cancer who received the experimental drug elraglusib alongside standard chemotherapy saw ...

Patients with previously treated metastatic pancreatic cancer lived roughly twice as long on a daily oral drug called daraxonrasib compared with standard chemotherapy, according to results from a ...

Clinical trials at Emory and Piedmont are signaling a potential breakthrough in treating pancreatic cancer, one of the nation’s deadliest diseases.

Exocrine cells make up much of the pancreas. When these cells grow out of control, adenocarcinoma of the pancreas occurs. Pancreatic adenocarcinomas account for about 95% of pancreatic cancers.

CLEVELAND — A disease with one of the lowest survival rates in oncology may have a new weapon — and the early results are offering something patients and their families rarely hear: hope. Pancreatic ...

Scientists at Oregon Health & Science University have developed a new technique using an electronic jolt and nanoparticles to reveal the telltale signal of an insidious form of cancer. The technique, ...

Please provide your email address to receive an email when new articles are posted on . Rates of pancreatic adenocarcinoma increased significantly among younger individuals than older ones. Colorectal ...

Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it has begun treating patients in RASolute 305, ...

While previous studies have suggested some benefits of consuming small amounts of alcohol, recent science suggests that no amount of alcohol consumption is risk-free, leading the U.S. Surgeon General ...